Masimo Corporation, a medical device maker focused on the pulse oximetry market, priced its IPO last night at $17 per share, the midpoint of its proposed range. The deal consisted of 11.9 million shares, 10.4 million of which were sold by insiders. Piper Jaffray, Deutsche Bank and Citi managed the deal for the Irvine, CA-based company. The stock is expected to begin trading this morning on the NASDAQ under the ticker MASI.
